Literature DB >> 14560572

Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.

Niall Swan1, Martha Skinner, Carl J O'Hara.   

Abstract

We retrospectively reviewed 100 bone marrow core biopsy specimens from patients with AL (primary) amyloidosis. The morphologic and immunohistochemical features were assessed by standard histochemical stains (H&E, periodic acid-Schiff, Congo red) and immunohistochemical stains for light chain immunoglobulins. Bone marrow core biopsy revealed a plasma cell dyscrasia in 83% (lambda, 65; kappa, 18) of cases. Amyloid deposits were observed in 60% of the bone marrow core biopsy specimens and, when present, were detected most often in blood vessel walls only (39/60). However, if present, interstitial amyloid deposition was significantly more associated with patients with a monoclonal kappa light chain gammopathy (P = .04). Through the careful analysis of standard histochemical and immunohistochemical stains, bone marrow core biopsy provides essential diagnostic information in cases of AL amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560572     DOI: 10.1309/PFUG-HBX0-TY20-E08U

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  Abdominal subcutaneous fat pad aspiration and bone marrow examination for the diagnosis of AL amyloidosis: the reliability of immunohistochemistry.

Authors:  Kanji Miyazaki; Shigeo Kawai; Kenshi Suzuki
Journal:  Int J Hematol       Date:  2015-06-27       Impact factor: 2.490

2.  Isolated mediastinal amyloidosis mimicking a neoplastic lesion.

Authors:  Alfonso Fiorelli; Marina Accardo; Giuseppe Ciancia; Guido Pettinato; Mario Santini
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-13

3.  Extensive amyloid deposit in bone marrow aspirate.

Authors:  Arvind Ahuja; Pawni Prabhat; Archana Rastogi; Dipanjan Panda; Chandan K Kumar; Shiv Kumar Sarin
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-01       Impact factor: 0.900

Review 4.  Amyloidosis: pathogenesis and new therapeutic options.

Authors:  Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

5.  Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan.

Authors:  Ping Zhou; Julie Teruya-Feldstein; Ping Lu; Martin Fleisher; Adam Olshen; Raymond L Comenzo
Journal:  Blood       Date:  2007-11-02       Impact factor: 22.113

6.  The amyloidoses: clinical features, diagnosis and treatment.

Authors:  Kelty R Baker; Lawrence Rice
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

7.  Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment.

Authors:  Andrew J Cowan; David C Seldin; Martha Skinner; Karen Quillen; Gheorghe Doros; Josenia Tan; Carl O'Hara; Kathleen T Finn; Vaishali Sanchorawala
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-27       Impact factor: 5.742

8.  Primary Amyloidosis - In a Case with Normal Plasma Cell Counts.

Authors:  Pooja Trehan; Mangala Gouri; Clement Wilfred; K Rashmi; Vijaya Mysorekar
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 9.  Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature.

Authors:  Vincenzo Di Crescenzo; Alfredo Garzi; Fara Petruzziello; Mariapia Cinelli; Lucio Catalano; Pio Zeppa; Mario Vitale
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

10.  Case 5: a 73 year-old man with heart failure, preserved systolic function and associated renal failure.

Authors:  Tiago Rodrigues Politi; Paulo Sampaio Gutierrez
Journal:  Arq Bras Cardiol       Date:  2013-11       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.